Company intelligence / Profile preview

Alcediag

Montpellier, Occitania, Francealcediag-alcen.com ↗

Ownership: Private
Development stage: Commercial

Overview

Alcediag has developed a panel of blood biomarkers based on RNA editing combined with artificial intelligence that shows high performance in diagnosing bipolar patients versus those with major depressive disorder. The company’s lead product (“EDIT-B”) has been validated in two independent cohorts. The company’s broader pipeline includes companion diagnostics and monitoring tools leveraging its proprietary epigenetic/RNA/AI platform.

Therapeutic areas: Psychiatry
Modalities: Diagnostic test (blood-based)Companion diagnosticBiomarker discovery platform (RNA-based)Cell-based assay (for drug impact modeling)
Industry: Molecular Diagnostics

Drug pipeline

2 assets

EDIT-B

Commercial

Indications: Bipolar disorder, Depression

1 more asset in the full pipeline.

Request access →

Partnerships

Engaged with pharmaceutical companies and medical laboratories; seeking further partnerships within pharma/diagnostics industry but no specific partners named publicly yet.

Beyond the preview

Go deeper on Alcediag.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcediag.

Explore the full profile